In response to a lawsuit, the FDA has said that it will reevaluate its previous decision to remove tirzepatide from its ...
Studies show that people with obesity are more likely to find that ill health affects their productivity and attendance at work.
The FDA is weighing a decision that could stop compounding pharmacies from legally making cheaper versions of Mounjaro and ...
Medicare coverage of the drugs would up federal spending by $35 billion from 2026 to 2034. Meanwhile, CNBC tests Abbott’s ...
A pharmacist warns that off-brand Ozempic, Zepbound, and other weight loss products carry undisclosed risks for consumers.
PBMs are putting weight loss drugs, including Wegovy and Zepbound, on their national formularies, but coverage by plans is ...
The changes coming with the new year — including a lower cap on out-of-pocket prescription-drug costs and a new program designed to help enrollees spread out their medication costs over the ...
Popular weight loss drugs are so pricey that many may shell out hundreds or even thousands of dollars on them. Some ...
The surge in popularity of drugs like Ozempic, driven in part by its weight loss benefits, is contributing to a record-high ...
Poor purity can cause patients to experience fever, chills, nausea, skin irritation, infections and low blood pressure.
That’s according to a new Employer Health Benefits Survey from KFF (formerly the Kaiser Family Foundation). But while a ...
If you’re living with diabetes, learn why you may be at greater risk for opioid use (and misuse) and what to do about it.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback